Physician profile
Sreenivas Koka
NPI 1699753319
$495,959.25
in general payments reported to CMS, 2019-2025
12 companies · $361K in 2025
The $361K reported for 2025 was more than what 99% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,161 · 2021: $3,908 · 2022: $2,802 · 2023: $18K · 2024: $95K · 2025: $361K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $368K · Travel and Lodging: $53K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $41K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Long Term Medical Supply Or Device Loan: $4,622 · Food and Beverage: $862 · Gift: $38.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $367,654.01 |
| Travel and Lodging | $53,203.03 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $41,224.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Long Term Medical Supply Or Device Loan | $4,622.00 |
| Food and Beverage | $861.54 |
| Gift | $38.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $403,969.33 | 2024-2025 | Education |
| Nobel Biocare USA | $36,211.65 | 2019-2023 | Education, Nobelactive |
| Neoss, INC. | $30,668.83 | 2021-2024 | Neoss Implant System |
| Prismatik Dentalcraft, INC. | $22,215.03 | 2024-2025 | |
| Keystone Dental INC. | $1,700.00 | 2020 | |
| Ivoclar Vivadent, INC. | $898.33 | 2020-2024 | |
| Zimvie INC. | $137.58 | 2024 | |
| Dentsply Sirona INC | $78.78 | 2019-2024 | Primescan Connect |
| Biohorizons Implant Systems INC. | $28.06 | 2019 | |
| Biolase, INC. | $23.70 | 2019 | |
| Dentsply Ih INC. | $16.42 | 2019 | |
| Kulzer, LLC | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreenivas Koka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.